Study protocol : azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants

Lowe, J., Gillespie, D., Hubbard, M. et al. (10 more authors) (2020) Study protocol : azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ Open, 10 (10). e041528.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 Author(s) (or their employer(s)). This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: chronic airways disease; neonatology; paediatric thoracic medicine; Azithromycin; Child; Chronic Disease; Dexamethasone; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lung Diseases; Randomized Controlled Trials as Topic; Wales
Dates:
  • Accepted: 14 August 2020
  • Published (online): 6 October 2020
  • Published: 6 October 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield
Depositing User: Symplectic Sheffield
Date Deposited: 25 Aug 2021 09:40
Last Modified: 25 Aug 2021 10:26
Status: Published
Publisher: BMJ Publishing Group
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmjopen-2020-041528
Related URLs:

Share / Export

Statistics